| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
8,140,000 |
| Market
Cap: |
12.13(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.165 - $3.25 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cocrystal Pharma is a biotechnology company engaged in discovering and developing antiviral therapeutics as treatments for serious and/or chronic viral diseases. Co. is developing antiviral therapeutics that inhibit the viral replication function of RNA viruses causing acute and chronic viral diseases. Co.'s targets include treating influenza virus, coronavirus and norovirus infections by discovering and developing drug candidates targeting the viral replication process. Additionally, Co. is targeting to decrease the duration of Hepatitis C virus (HCV) therapy by developing its drug candidate targeting HCV RNA-dependent RNA polymerase enzyme through partnerships and/or licensing activities.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Japour Anthony J |
Director |
– • – |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
14,924 |
14,924 |
|
- |
|
| Pfenniger Richard C Jr |
Director |
– • – |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8,067 |
11,400 |
|
- |
|
| Martin James Joseph |
Co-CEO and CFO |
• – – |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,569 |
|
- |
|
| Frost Phillip Md Et Al |
Director |
– • • |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
27,100 |
27,100 |
|
- |
|
| Kornberg Roger D. |
Director |
– • – |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
28,109 |
28,109 |
|
- |
|
| Lee Sam |
President and Co-CEO |
• – – |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
76,355 |
|
- |
|
| Hassan Fred |
Director |
– • – |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8,067 |
1,023,296 |
|
- |
|
| Rubin Steven D |
Director |
– • – |
2024-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
18,957 |
2,660,242 |
|
- |
|
| Hassan Fred |
Director |
– • – |
2023-04-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,015,229 |
|
22% |
|
| Frost Gamma Investment Trust |
10% Owner |
– – • |
2023-04-04 |
4 |
B |
$1.97 |
$2,000,001 |
I/I |
1,015,229 |
1,319,838 |
1.5 |
47% |
|
| Pfenniger Richard C Jr |
Director |
– • – |
2021-08-20 |
4 |
B |
$1.03 |
$41,120 |
D/D |
40,000 |
40,000 |
2.39 |
- |
|
| Schinazi Raymond F |
10% Owner |
– – • |
2021-05-04 |
4 |
S |
$2.95 |
$1,696,250 |
D/D |
(575,000) |
7,674,960 |
|
- |
|
| Kornberg Roger D. |
Director |
– • – |
2020-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
477,217 |
|
- |
|
| Schinazi Raymond F |
10% Owner |
– – • |
2019-10-25 |
4 |
B |
$1.15 |
$9,092 |
D/D |
7,906 |
9,257,863 |
2.37 |
- |
|
| Schinazi Raymond F |
10% Owner |
– – • |
2019-10-24 |
4 |
B |
$1.15 |
$5,858 |
D/D |
5,094 |
9,249,957 |
2.37 |
- |
|
| Schinazi Raymond F |
10% Owner |
– – • |
2019-10-23 |
4 |
B |
$1.04 |
$4,087 |
D/D |
3,935 |
9,244,863 |
2.37 |
- |
|
| Schinazi Raymond F |
Director |
– • • |
2018-05-10 |
4 |
A |
$1.90 |
$19,397 |
I/I |
10,209 |
995,593 |
|
- |
|
| Schinazi Raymond F |
Director |
– • • |
2018-05-10 |
4 |
OE |
$1.90 |
$500,000 |
I/I |
263,158 |
985,384 |
|
- |
|
| Frost Gamma Investment Trust |
Trustee |
– – – |
2018-05-03 |
4 |
A |
$1.90 |
$200,000 |
I/I |
105,263 |
3,655,265 |
|
- |
|
| Schinazi Raymond F |
Director |
– • • |
2018-05-03 |
4 |
A |
$1.90 |
$799,400 |
I/I |
420,737 |
722,226 |
|
- |
|
| Schinazi Raymond F |
Director |
– • • |
2017-07-11 |
4 |
OE |
$0.05 |
$80,228 |
D/D |
1,706,978 |
277,227,831 |
|
- |
|
| Schinazi Raymond F |
Director |
– • • |
2017-04-20 |
4 |
A |
$0.24 |
$1,000,000 |
I/I |
4,166,667 |
9,044,717 |
|
- |
|
| Lee Sam |
PRESIDENT |
• – – |
2016-12-23 |
4 |
S |
$0.44 |
$968,000 |
D/D |
(2,200,000) |
13,087,847 |
|
- |
|
| Block David S |
|
– • – |
2016-09-01 |
4 |
B |
$0.41 |
$4,100 |
D/D |
10,000 |
168,696 |
2.31 |
- |
|
| Schinazi Raymond F |
|
– • • |
2016-09-01 |
4 |
B |
$0.41 |
$2,000,000 |
I/I |
4,878,050 |
4,878,050 |
2.25 |
- |
|
35 Records found
|
|
Page 1 of 2 |
|
|
